Attendere, elaborazione in corso…

Logo PROGETTO UE PROCARDIO

PROCARDIO

Cardiovascular Risk from Exposure to Low-dose and Low-dose-rate Ionizing Radiation

Informazioni Generali

Coordinatore:
HELMHOLTZ-ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH (Germania)
Responsabile ENEA:
SARAN ANNA - SSPT-TECS-TEB (CASACCIA)
Ruolo ENEA:
PARTNER
Sito WEB:
Sito WEB non disponibile

Descrizione e Attività

Descrizione Generale

Epidemiological evidence has established a link between cardiovascular disease and exposure of the heart and major vessels to doses above 500mGy. At lower doses the evidence for a detrimental effect is inconclusive. In part, this is due to the lack of appropriate epidemiological studies, coupled with lack of knowledge of the processes involved that is needed for construction of mathematical models. The ProCardio consortium will study cardiovascular outcomes in childhood cancer survivors where the radiation doses given to the heart are available. These data will be interrogated using new mathematical models developed from the data from our molecular and biological studies. These will use state-of-the-art technologies to map cardiovascular changes after photon irradiation at both low doses and low dose rates. This will be complemented by comparative studies using high LET irradiation. We will apply an integrative approach to combine transcriptional (mRNA and miRNA) and translational (proteomics) studies to understand the disease processes. High throughput proteomics (ICPL, SILAC and label-free analysis) will be used to identify new biomarkers of radiation-induced cardiovascular disease for future molecular epidemiological studies. These will be validated using the archives of cardiovascular tissue samples from the Mayak facility.

Attività svolta da ENEA

L'ENEA coordina il Workpackage 5 "Effect of Dose Rate" e contribuisce al Workpackage 6 “Complex tissue interactions in radiation-induced vascular disease”.

Programmi Europei

Programma:
Settimo Programma Quadro Euratom (2007-2013) → Euratom fissione (CP-FP - Progetto di collaborazione-progetto mirato)

Dati Finanziari (in euro)

Costo Eleggibile

Progetto:
5.945.179,00
ENEA:
369.991,00

Contributo

Al progetto:
2.998.386,00
A ENEA:
184.995,00

Durata del Progetto

Anno di stipula e Durata:
2011 - 36 mesi
Periodo:
01-10-2011 → 31-03-2015

Numero di Partner (12)

Ruolo Tipologia Nome Nazione
Istituti di ricerca SCK CEN - STUDIECENTRUM VOOR KERNENERGIE / CENTRE D'ETUDE DE L'ENERGIE NUCLEAIRE Belgio
Istituti di ricerca INSTITUT GUSTAVE ROUSSY Francia
Società di consulenza GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O Germania
Istituti di ricerca GSI HELMHOLTZZENTRUM FUER SCHWERIONENFORSCHUNG GMBH Germania
Istituti di ricerca RIVM - NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT Paesi Bassi
Università UNIV. AMSTERDAM (UVA) Paesi Bassi
Istituti di ricerca HPA - HEALTH PROTECTION AGENCY Regno Unito
Università UNIV. BIRMINGHAM Regno Unito
Istituti di ricerca FEDERAL STATE UNITARY ENTERPRISE SOUTHERN URALS BIOPHYSICS INSTITUTE OF FEDERAL MEDICOBIOLOGICAL AGENCY Russia
Istituti di ricerca CREAL FUNDACIO CENTRE DE RECERCA EN EPIDEMIOLOGIA AMBIENTAL Spagna
COORD Istituti di ricerca HELMHOLTZ-ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH Germania
PARTNER Istituti di ricerca ENEA Italia

Keyword associate al progetto dal database di CORDIS (3)

Keyword Argomento Macro
MEDICINE, HEALTH Biological Sciences MEDICINE, HEALTH
NUCLEAR FISSION Energy NUCLEAR FISSION
RADIATION PROTECTION Protecting Man and his Environment RADIATION PROTECTION

Altre Keyword non presenti nel database di CORDIS (1)

Keyword
Low dose